Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday that ...

Weybridge-based Haleon is a consumer healthcare products manufacturer which owns brands such as Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. According to JPMorgan, Pfizer ...

The latest disposal reduced Pfizer's interest in Haleon to 7.3% from 15%. JPMorgan and Morgan Stanley acted as joint global coordinators and joint bookrunners for the sale. GSK sold its remaining 4.2% ...

EpiPens are a life-saving treatment for severe allergic reactions. Indiana's AG says Pfizer and Mylan have broken the law to ...

Green, a former pharmacist and pharma ad copywriter whose resume includes such agencies as Grey Healthcare and KPR (since ...

Pfizer will sell shares worth £2.50 billion ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%.

A dip in inflation today eased pressure on Rachel Reeves and boosted hopes of a February interest rate cut. On the corporate ...

Kenvue isn't growing as quickly as Eli Lilly or Zoetis, but it offers investors a strong starting point for dividend income.

Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and ...